Shawn O'connor
About Shawn O'connor
Shawn O'Connor is the Senior Territory Business Manager for Cardiovascular at Bristol-Myers Squibb, with over a decade of experience in cardiovascular territory management and a strong background in sales and diabetes care.
Current Role at Bristol-Myers Squibb
Shawn O'Connor currently holds the position of Senior Territory Business Manager for Cardiovascular at Bristol-Myers Squibb. Based in the Grand Junction, Colorado area, he is responsible for managing the cardiovascular territory. His role involves strategizing and implementing business plans to drive sales and foster customer relationships within the cardiovascular segment.
Previous Experience at Novo Nordisk
Before his tenure at Bristol-Myers Squibb, Shawn O'Connor worked at Novo Nordisk. From 2008 to 2011, he served as a Diabetes Care Specialist and Diabetes Care Specialist III. During these three years, he gained valuable experience in diabetes care, supporting physicians and healthcare providers in managing diabetes treatment protocols.
Early Career in Pharmaceutical Sales
Shawn O'Connor began his career in the pharmaceutical industry in 2000. He worked at Key Pharmaceuticals and Schering-Plough Corp as a Sales Representative. Over eight years, he honed his sales skills, engaging with healthcare professionals and promoting pharmaceutical products to help meet the needs of patients.
Educational Background
Shawn O'Connor earned his Bachelor of Business Administration with a double emphasis in Marketing and Management from Colorado Mesa University. He attended FMHS/Mesa State before completing his degree at Colorado Mesa University from 1992 to 1996. His educational background laid a solid foundation for his career in the pharmaceutical and healthcare industries.
Extensive Experience in Cardiovascular Management
With over a decade of experience in cardiovascular territory management at Bristol-Myers Squibb, Shawn O'Connor brings extensive knowledge and expertise to his role. His responsibilities include developing and executing strategic plans to drive growth in the cardiovascular segment. Since starting with the company in December 2011, he has been dedicated to improving cardiovascular care and promoting the company's products.